21 CFR § 200.51 General

§ 200.51 Aqueous-based drug products for oral inhalation.

Current through Sep 8, 2026 · Read all of Part 200

(a) All aqueous-based drug products for oral inhalation must be manufactured to be sterile.

(b) Manufacturers must also comply with the requirements in § 211.113(b) of this chapter.

[65 FR 34089, May 26, 2000]

← § 200.50 Ophthalmic preparations and dispensers.§ 200.200 Prescription drugs; reminder advertisements and reminder labeling to provide price information to consumers. →